Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rising Cases Of NCDs Prompts Indian Government To Step Up Healthcare, Screening Programs

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Alarmed by the rapid increase in the number of non-communicable diseases, India's ministry of health and family welfare announced that the recently unveiled National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke will be extended to the entire country over the next five years

You may also be interested in...

Pfizer’s Jack Watters On Healthy Ageing In Emerging Markets: An Interview With PharmAsia News (Part 1 of 2)

Jack Watters is Pfizer’s vice president for External Medical Affairs and holds global responsibilities for relations with medical societies, academic institutions and government health bodies around the globe. He discusses one of the most pressing issues for public health policymakers worldwide – how to care for ageing populations.

As India’s Diabetes Market Grows, Eli Lilly Brings In A New Leader

With an eye on diabetes and non-communicable diseases, Lilly taps new leadership in India.

Catch’em Young! India Launches Screening Drive For Juvenile Diabetes

With 1 million children having type 1 diabetes, India gets into grassroots investigations.

Related Content

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts